Cadila falls on earnings, broker downgrades

MUMBAI Mon Feb 11, 2013 9:38am IST

A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo. REUTERS/Mark Blinch/Files

A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo.

Credit: Reuters/Mark Blinch/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.

Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.

Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.

(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Press Event

Press Event

Modi takes tea, but no questions, in first press event as PM.  Full Article 

Monetary Policy

Monetary Policy

Finance Minister Arun Jaitley favours interest rate cut - paper  Full Article 

Sundar Pichai Elevated

Sundar Pichai Elevated

Google's Pichai to oversee major products and services.  Full Article 

Reuters Poll

Reuters Poll

India's growth pace to pick up as reforms draw investment   Full Article 

Need For Reforms

Need For Reforms

Euro zone risks "relapse into recession" without structural reforms - Draghi.  Full Article 

Diwali Sales

Diwali Sales

Gold sales jump about 20 pct for Diwali - trade body  Full Article 

World Bank Rival

World Bank Rival

Three major nations absent as China launches W.Bank rival in Asia  Full Article 

Health Of Lenders

Health Of Lenders

25 European banks set to fail health checks - sources.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage